{"annotatable":{"parts":["s1v1","s2v1","s3v1","s4v1","s5v1","s6v1","s7v1","s8v1","s9v1","s10v1","s11v1","s12v1","s13v1"]},"anncomplete":true,"sources":[],"metas":{"m_82":{"value":"High-risk","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}},"m_83":{"value":"High-risk","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}},"m_84":{"value":"High-risk","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}},"m_85":{"value":"Low-risk","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}},"m_86":{"value":"High-risk","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}},"m_35":{"value":"High-risk","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}}},"entities":[{"classId":"e_109","part":"s1v1","offsets":[{"start":312,"text":"a randomised, double‑blind, placebo‑controlled clinical study"}],"coordinates":[{"x":"315.45","y":"144.88"},{"x":"259.94","y":"172.58"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_130","part":"s1v1","offsets":[{"start":326,"text":"double‑blind, placebo‑controlled"}],"coordinates":[{"x":"409.67","y":"144.88"},{"x":"173.28","y":"172.58"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_109","part":"s1v1","offsets":[{"start":1025,"text":"A total of 131 children, out of the planned 320, were recruited into the study during 1 common cold season and randomised to consume once daily either  109 CFU (colony forming units) of the probiotic product or placebo. Due to unfore-seen reasons, the recruitment of more children did not continue beyond the first cold season."}],"coordinates":[{"x":"91.81","y":"326.11"},{"x":"422.28","y":"357.73"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_116","part":"s2v1","offsets":[{"start":969,"text":"The study was randomised, double-blind, placebo-controlled with  the  objective  to  evaluate  the  efficacy  of  Lactobacil-lus plantarum HEAL9 and Lactobacillus paracasei 8700:2 as compared to placebo, on the incidence of upper respira-tory tract infections (URTIs) in children attending day care."}],"coordinates":[{"x":"51.02","y":"321.14"},{"x":"289.11","y":"377.76"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_109","part":"s2v1","offsets":[{"start":969,"text":"The study was randomised, double-blind, placebo-controlled with  the  objective  to  evaluate  the  efficacy  of  Lactobacil-lus plantarum HEAL9 and Lactobacillus paracasei 8700:2 as compared to placebo, on the incidence of upper respira-tory tract infections (URTIs) in children attending day care"}],"coordinates":[{"x":"51.02","y":"321.14"},{"x":"286.57","y":"377.76"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_125","part":"s2v1","offsets":[{"start":995,"text":"double-blind, placebo-controlled"}],"coordinates":[{"x":"160.02","y":"321.14"},{"x":"288.95","y":"327.76"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_185","part":"s2v1","offsets":[{"start":995,"text":"double-blind, placebo-controlled"}],"coordinates":[{"x":"160.02","y":"321.14"},{"x":"288.95","y":"327.76"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_180","part":"s2v1","offsets":[{"start":995,"text":"double-blind, placebo-controlled"}],"coordinates":[{"x":"160.02","y":"321.14"},{"x":"288.95","y":"327.76"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_205","part":"s2v1","offsets":[{"start":1660,"text":"The recruitment was initiated in September 2013 and by the end of the common cold season 2013–2014, there were 131 children randomised out of 193 screened. The recruitment was paused during the summer months with the aim to be continued in the follow-ing  season  of  2014–2015.  However,  due  to  closedown  of the  clinical  research  organization  (CRO),  the  recruitment of  more  study  participants  did  not  continue  after  the  first common cold season and the total number of children ran-domised remained at 131"}],"coordinates":[{"x":"206.38","y":"458.64"},{"x":"152.55","y":"577.76"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s3v1","offsets":[{"start":1422,"text":"The children were randomly allocated to receive probiotic product or placebo based on a computer-generated  randomization  list  with  blocks  of  four."}],"coordinates":[{"x":"120.51","y":"370.26"},{"x":"257.87","y":"401.88"}],"confidence":{"state":"pre-added","who":["user:anjDhr"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_176","part":"s3v1","offsets":[{"start":1893,"text":"The primary objective of the study was to show the ben-efit from using the probiotic combination as compared to placebo, on the incidence of upper respiratory infections during the intervention period of 90 days."}],"coordinates":[{"x":"51.02","y":"507.76"},{"x":"226.72","y":"551.88"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_180","part":"s3v1","offsets":[{"start":2106,"text":"Incidence was defined  as  the  number  of  children  repor ting  at  least  one infection."}],"coordinates":[{"x":"229.85","y":"545.26"},{"x":"91.48","y":"576.88"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_150","part":"s3v1","offsets":[{"start":3839,"text":"The predefined main analysis set included subjects with no major protocol deviations (as evaluated before breaking the randomization code) and a compliance of at least 80% intake of study product (PP population)."}],"coordinates":[{"x":"317.48","y":"307.76"},{"x":"470.13","y":"351.88"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_204","part":"s3v1","offsets":[{"start":3839,"text":"The predefined main analysis set included subjects with no major protocol deviations (as evaluated before breaking the randomization code) and a compliance of at least 80% intake of study product (PP population). However, data on the primary endpoint, incidence of common cold episodes, are also presented for the intention to treat (ITT) population. In addition, a theoretical projection of the obtained results, to the aimed number of approximately 300 participants, was applied using each participant three times. It was assumed that the difference between the groups remained the same in the population of 300 children as obtained in the population of 99. Data on safety are presented for the ITT population only"}],"coordinates":[{"x":"317.48","y":"307.76"},{"x":"323.86","y":"464.38"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_215","part":"s3v1","offsets":[{"start":3839,"text":"The predefined main analysis set included subjects with no major protocol deviations (as evaluated before breaking the randomization code) and a compliance of at least 80% intake of study product (PP population). However, data on the primary endpoint, incidence of common cold episodes, are also presented for the intention to treat (ITT) population. In addition, a theoretical projection of the obtained results, to the aimed number of approximately 300 participants, was applied using each participant three times. It was assumed that the difference between the groups remained the same in the population of 300 children as obtained in the population of 99. Data on safety are presented for the ITT population only."}],"coordinates":[{"x":"317.48","y":"307.76"},{"x":"325.70","y":"464.38"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_165","part":"s3v1","offsets":[{"start":4805,"text":"In total, 25 children discontinued the study (11.4%) mostly due to parental withdrawal of informed consent. There were 106  children  who  completed  the  study,  48  (76.2%)  in  the probiotic and 58 (85.3%) in the placebo group"}],"coordinates":[{"x":"306.14","y":"582.76"},{"x":"488.49","y":"626.88"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_154","part":"s3v1","offsets":[{"start":5036,"text":"Out of these, 7  presented  with  major  protocol  deviations  and  44  in  the probiotic compared to 55 in the placebo group were found to be eligible for inclusion in the PP population"}],"coordinates":[{"x":"493.24","y":"620.26"},{"x":"504.63","y":"664.38"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_120","part":"s4v1","offsets":[{"start":1966,"text":"Table 1   Baseline characteristics (ITT population)Total Probi  Defendum® PlaceboChildren randomised, n (%) 131 (100) 63 (48.1) 68 (51.9)Males, n (%) 75 (57.2) 32 (50.8) 43 (63.2)Females, n (%) 56 (42.7) 31 (49.2) 25 (36.8)Age in years. mean (SD) 3.1 ± 1.4 3.1 ± 1.4 3.1 ± 1.4 1–2 years old, n (%) 48 (36.6) 24 (38.1) 24 (35.3) 3–4 years old, n (%) 54 (41.2) 24 (38.1) 29 (42.6) 5–6 years old, n (%) 30 (22.9) 15 (23.8) 15 (22.1)"}],"coordinates":[{"x":"51.02","y":"284.18"},{"x":"288.63","y":"409.97"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}}],"relations":[]}